AbbVie Inc. diskutieren
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
190,40 €
-0,94 %
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $241.00 to $250.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Evercore ISI from $204.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Guggenheim from $214.00 to $216.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $231.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at Wells Fargo & Company from $240.00 to $260.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at BMO Capital Markets from $215.00 to $240.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at Cantor Fitzgerald from $215.00 to $245.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at JPMorgan Chase & Co. from $200.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating. They now have a $270.00 price target on the stock, up previously from $170.00.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at Evercore ISI from $207.00 to $222.00. They now have an "outperform" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) was given a new $250.00 price target on by analysts at Cantor Fitzgerald. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at Guggenheim from $227.00 to $242.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its price target raised by analysts at JPMorgan Chase & Co. from $250.00 to $260.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $289.00 price target on the stock, up previously from $284.00.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for ABBV provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Amazon.com Inc. diskutieren